Addition/Correction pubs.acs.org/jmc
Correction to 3‑Thiomorpholin-8-oxo‑8H‑acenaphtho[1,2‑b]pyrrole9-carbonitrile (S1) Based Molecules as Potent, Dual Inhibitors of B‑Cell Lymphoma 2 (Bcl-2) and Myeloid Cell Leukemia Sequence 1 (Mcl-1): Structure-Based Design and Structure−Activity Relationship Studies Ting Song,† Qingbin Chen,‡ Xiangqian Li,† Gaobo Chai,‡ and Zhichao Zhang*,† †
School of Chemistry, Dalian University of Technology, Dalian 116012, People’s Republic of China School of Life Science and Technology, Dalian University of Technology, Dalian 116024, People’s Republic of China
‡
Journal of Medicinal Chemistry 2011, 54, 1101−1105. DOI: 10.1021/jm101181u S Supporting Information *
Page 1102. In Scheme 1, the structures of 3 (S1) and 6a−i should be corrected as follows:
Page 1102. Figure 1c should be corrected as follows:
Published: November 13, 2013 © 2013 American Chemical Society
9366
dx.doi.org/10.1021/jm401588g | J. Med. Chem. 2013, 56, 9366−9367
Journal of Medicinal Chemistry
Addition/Correction
Page 1103. Figure 3b should be corrected as follows:
■
ASSOCIATED CONTENT
S Supporting Information *
Detailed explanation of the errors. This material is available free of charge via the Internet at http://pubs.acs.org.
■
AUTHOR INFORMATION
Corresponding Author
*Phone: 86-411-84986032. Fax: 86-411-84986032. E-mail:
[email protected].
9367
dx.doi.org/10.1021/jm401588g | J. Med. Chem. 2013, 56, 9366−9367
